WeWork delays IPO after frosty investor response
WeWork owner The We Company has postponed its initial public offering (IPO), walking away from preparations to launch it this month after a lackluster response...
Saudi Aramco pursues IPO planning despite attack damage doubts
Saudi Aramco is pressing ahead with its listing plans this week, although some investors and analysts doubt it can now meet its timeline as it...
AB Inbev launches second Asia IPO attempt, targets up to $6.6 billion
Anheuser-Busch InBev NV will kick off a second attempt to spin off its Asian business in Hong Kong with the launch on Wednesday of an...
Oil slips as market assesses fallout from Saudi attack
Oil prices slid on Tuesday, although the market remains on tenterhooks over the threat of a military response to attacks on Saudi Arabian crude oil...
Apple says $14 billion EU tax order ‘defies reality and common sense’
The European Union’s order for Apple to pay 13 billion euros ($14 billion) in back taxes to Ireland “defies reality and common sense,” the U.S....
Oil sheds gains, stocks inch lower as focus turns to Fed
Oil shed some of its massive gains on Tuesday as the United States flagged the possible release of crude reserves, while stocks inched lower as...
Fund managers have not joined race into cheap, value stocks: BAML survey
Fund managers have not piled into so-called value stocks, which have been shunned during the decade-long technology-led boom, even as shares in beaten-down companies have...
U.S., Chinese trade deputy talks to start on Thursday
Deputy-level U.S.-China trade talks are scheduled to start in Washington on Thursday, the U.S. Trade Representative’s office said, paving the way for high-level talks in...
Factbox: Britain’s insulin providers prepare for Brexit fallout
With Britain sourcing the vast majority of the insulin needed by its 1 million diabetics from overseas, its biggest providers have had to restructure their...
With a backup to the backup, insulin makers say they’re primed for Brexit
For two men trained as scientists, the bosses of Britain’s major insulin providers have had to become experts in ferry schedules, trucking laws and warehouse...